Public Storage
PSA-PH News Today: Stay Updated with the Latest Public Storage News in Real Time
Find PSA-PH news now at Meyka AI. Stay informed with the latest Public Storage stocks updates, including price news, market analysis, and expert insights.
ABT.SW Abbott Laboratories (SIX) down 13.50% pre-market: CHF86.50 support to watch
Pre-market: ABT.SW stock falls 13.50% to CHF86.50 on 24 Feb 2026; oversold technicals and Meyka AI projects CHF100.56 target
Pre-market volume spike 94x on 5935.T Gantan Beauty Industry (JPX): Model shows 18.79% upside
Pre-market volume spike in 5935.T stock on 24 Feb 2026; volume 1700 vs avg 18 and model shows 18.79% upside
February 24: El Mencho’s Death Spurs Mexico Security, Travel Risk Watch
El Mencho’s reported death triggers a Mexico security and travel risk watch. What Hong Kong investors should track on transport, CJNG leadership shifts, and near-term volatility.
Hong Kong 35+ Appeal: Lau Wai-chung Acquittal Upheld – February 24
Lau Wai-chung acquittal upheld: Hong Kong Court of Appeal rejects 12 appeals in the 35+ primary case, keeps 4.5–7.75-year sentences, reinforcing Hong Kong NSL risks for investors.
DIDAF $21.60 on PNK: Distribuidora Internacional top gainer 23 Feb 2026
DIDAF stock hits $21.60 on PNK; low-volume spike ahead of earnings with Meyka AI forecast showing 40.87% yearly upside
^GSPC Today: February 23 – DHS PreCheck U-turn, Global Entry Still Paused
DHS reversed plans to suspend TSA PreCheck while Global Entry stays paused amid a partial government shutdown. How this “global entry tsa precheck shut” debate could impact airport flow, airlines, and
SPYI.DE falls 96% to €10.31 on XETRA (23 Feb 2026): key signals for investors
Market closed: SPYI.DE stock plunged 96% to €10.31 on XETRA on 23 Feb 2026; analysis, technicals and forecasts
February 24: Takaichi Cabinet 2.0 Backs Drug Investment, Biosimilar Parity
Takaichi Cabinet 2.0 backs public-private drug R&D and extends Japan drug pricing reform 2026 to biologics via the G1 rule, moving originator prices toward biosimilar parity. What it means for Japan’s
UBS Downgrades Gerresheimer AG (GRRMF) to Sell on Feb 23, 2026
UBS downgrades Gerresheimer; quick take on the Feb 23, 2026 GRRMF analyst rating and investor implications